معرفی
Prof. Wim Veling is a Professor at the University of Groningen's Faculty of Medical Sciences and leads the Clinical Cognitive Neuropsychiatry Research Program (CCNP) at UMCG. He also serves as Chief Scientific Officer at VRelax BV, focusing on innovative mental health solutions. His expertise spans psychosis, schizophrenia, and virtual reality (VR) applications in therapy.
Research Interests: Veling's work emphasizes VR-based interventions for mental health, clinical outcomes in psychosis, and improving social functioning post-remission. He actively collaborates internationally, contributing to studies like HAMLETT and PHAMOUS.
Recent Work Trends: His publications (2024-2025) highlight VR therapy efficacy, validation of clinical scales, and long-term recovery outcomes in schizophrenia. Articles often combine clinical data with innovative methodologies.
- Awards: Prix Galien Medtech Innovation Award (2021), Research Harmonisation Group Award (2020).
- Advising & Grants: Supervised 9 works; involved in datasets like the HAMLETT trial. Active in grant-funded projects on antipsychotic medication strategies.
Labs & Teams: Leads CCNP and collaborates with VRelax BV. Engaged with organizations like the Netherlands Psychiatric Association and Schizophrenia International Research Society.
